Nephros (NEPH) Current Assets (2010 - 2026)
Nephros (NEPH) posted quarterly Current Assets of $11.5 million for Q1 2026, up 27.85% year-over-year from $9.0 million in Q1 2025, and up 2.43% quarter-over-quarter from $11.2 million in Q4 2025.
Nephros (NEPH) Current Assets (2010 - 2026) Analysis & Trends
Nephros' Current Assets history runs 17 years deep, the most recent figure standing at $11.5 million for Q1 2026.
- In Q1 2026, Current Assets rose 27.85% year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $11.5 million (up 27.85% YoY), while the FY2025 annual figure was $11.2 million, up 35.25% from the prior year.
- Current Assets for Q1 2026 stood at $11.5 million, up from $11.2 million in the prior quarter.
- The five-year high for Current Assets was $11.7 million in Q1 2022, with the low at $7.4 million in Q3 2024.
- The 5-year median for Current Assets is $8.5 million (2023), against an average of $9.2 million.
- The sharpest annual moves came in 2022 and 2025: Current Assets plunged 39.41% in 2022, then surged 45.54% in 2025.
- Nephros' Current Assets stood at $8.3 million in 2022, then rose by 1.74% to $8.4 million in 2023, then retreated by 1.27% to $8.3 million in 2024, then surged by 35.25% to $11.2 million in 2025, then advanced by 2.43% to $11.5 million in 2026.
- Business Quant data shows NEPH's Current Assets at $11.5 million in Q1 2026, $11.2 million in Q4 2025, and $10.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 130.04 Bn | 124.82 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 51.73 Bn | 50.87 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.41 Bn | 34.06 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.27 Bn | 31.80 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 28.23 Bn | 25.55 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.55 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.29 Bn | 14.88 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.66 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Nephros | 47.88 Mn | 43.18 Mn | 4.03 Mn | 13.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.60 Mn |
| Mar 31, 2026 | 11.50 Mn |
| Dec 31, 2025 | 11.22 Mn |
| Sep 30, 2025 | 10.71 Mn |
| Jun 30, 2025 | 9.58 Mn |
| Mar 31, 2025 | 8.99 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 7.36 Mn |
| Jun 30, 2024 | 7.93 Mn |
| Mar 31, 2024 | 8.13 Mn |
| Dec 31, 2023 | 8.41 Mn |
| Sep 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 7.91 Mn |
| Mar 31, 2023 | 8.32 Mn |
| Dec 31, 2022 | 8.26 Mn |
| Sep 30, 2022 | 9.12 Mn |
| Jun 30, 2022 | 11.12 Mn |
| Mar 31, 2022 | 11.66 Mn |
| Dec 31, 2021 | 13.63 Mn |
| Sep 30, 2021 | 13.62 Mn |